spacer
spacer

PDBsum entry 2arv

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hormone/growth factor PDB id
2arv

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
116 a.a. *
106 a.a. *
Ligands
SO4 ×4
GOL ×3
1PG
Waters ×54
* Residue conservation analysis
PDB id:
2arv
Name: Hormone/growth factor
Title: Structure of human activin a
Structure: Inhibin beta a chain. Chain: a, b. Synonym: activin beta-a chain, erythroid differentiation protein, edf. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: inhba. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
Biol. unit: Dimer (from PQS)
Resolution:
2.00Å     R-factor:   0.218     R-free:   0.259
Authors: A.E.Harrington,S.A.Morris-Triggs,B.T.Ruotolo,C.V.Robinson,S.Ohnuma, M.Hyvonen
Key ref:
A.E.Harrington et al. (2006). Structural basis for the inhibition of activin signalling by follistatin. EMBO J, 25, 1035-1045. PubMed id: 16482217 DOI: 10.1038/sj.emboj.7601000
Date:
22-Aug-05     Release date:   07-Mar-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P08476  (INHBA_HUMAN) -  Inhibin beta A chain from Homo sapiens
Seq:
Struc:
426 a.a.
116 a.a.
Protein chain
Pfam   ArchSchema ?
P08476  (INHBA_HUMAN) -  Inhibin beta A chain from Homo sapiens
Seq:
Struc:
426 a.a.
106 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1038/sj.emboj.7601000 EMBO J 25:1035-1045 (2006)
PubMed id: 16482217  
 
 
Structural basis for the inhibition of activin signalling by follistatin.
A.E.Harrington, S.A.Morris-Triggs, B.T.Ruotolo, C.V.Robinson, S.Ohnuma, M.Hyvönen.
 
  ABSTRACT  
 
The secreted, multidomain protein follistatin binds activins with high affinity, inhibiting their receptor interaction. We have dissected follistatin's domain structure and shown that the minimal activin-inhibiting fragment of follistatin is comprised of the first and second Fs domains (Fs12). This protein can bind to activin dimer and form a stable complex containing two Fs12 molecules and one activin dimer. We have solved crystal structures of activin A alone and its complex with Fs12 fragment to 2 A resolution. The complex structure shows how Fs12 molecules wrap around the back of the 'wings' of activin, blocking the type II receptor-binding site on activin A. Arginine 192 in Fs2 is a key residue in this interaction, inserting itself in between activin's fingers. Complex formation imposes a novel orientation for the EGF- and Kazal-like subdomains in the Fs2 domain and activin A shows further variation from the canonical TGF-beta family fold. The structure provides a detailed description of the inhibitory mechanism and gives insights into interactions of follistatin with other TGF-beta family proteins.
 
  Selected figure(s)  
 
Figure 3.
Figure 3 Overall architecture of the activin–Fs12 complex. (A) View down the two-fold axis of symmetry showing the two follistatin fragments binding to the back of the activin A fingers. Activin protomers are coloured red and orange, the interchain disulphide is shown in yellow. Follistatin domains Fs1 and Fs2 are coloured blue and green, respectively. (B) A perpendicular view of the complex showing the closed conformation of activin and Fs12 fragments wrapping along the activin A, shown as a surface model.
Figure 6.
Figure 6 Interaction surface between activin and Fs12 and ActRIIB. Comparison of activin binding by Fs12 and the extracellular domain of the type II activin receptor (Greenwald et al, 2004; PDB:1s4y). Activin protomers are shown as molecular surfaces (orange and red), and the two Fs12 molecules (A, blue Fs1 and green Fs2) and two type II receptor domains (B, blue and green) are shown as ribbon diagrams. The activin surface is coloured dark grey over atoms that are closer than 4 Å from the interacting protein. Water molecules sandwiched between the two proteins are shown as light blue spheres. Both complexes are shown in the same orientation for the orange activin A protomer.
 
  The above figures are reprinted by permission from Macmillan Publishers Ltd: EMBO J (2006, 25, 1035-1045) copyright 2006.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
22398444 E.Harjunmaa, A.Kallonen, M.Voutilainen, K.Hämäläinen, M.L.Mikkola, and J.Jernvall (2012).
On the difficulty of increasing dental complexity.
  Nature, 483, 324-327.  
  21364553 R.Patani, A.J.Hollins, T.M.Wishart, C.A.Puddifoot, S.Alvarez, A.R.de Lera, D.J.Wyllie, D.A.Compston, R.A.Pedersen, T.H.Gillingwater, G.E.Hardingham, N.D.Allen, and S.Chandran (2011).
Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state.
  Nat Commun, 2, 214.  
19106105 A.L.Blount, K.Schmidt, N.J.Justice, W.W.Vale, W.H.Fischer, and L.M.Bilezikjian (2009).
FoxL2 and Smad3 Coordinately Regulate Follistatin Gene Transcription.
  J Biol Chem, 284, 7631-7645.  
  21160961 E.Kreidl, D.Oztürk, T.Metzner, W.Berger, and M.Grusch (2009).
Activins and follistatins: Emerging roles in liver physiology and cancer.
  World J Hepatol, 1, 17-27.  
19644449 J.N.Cash, C.A.Rejon, A.C.McPherron, D.J.Bernard, and T.B.Thompson (2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
  EMBO J, 28, 2662-2676.
PDB code: 3hh2
19926516 J.Nickel, W.Sebald, J.C.Groppe, and T.D.Mueller (2009).
Intricacies of BMP receptor assembly.
  Cytokine Growth Factor Rev, 20, 367-377.  
19538713 K.Tsuchida, M.Nakatani, K.Hitachi, A.Uezumi, Y.Sunada, H.Ageta, and K.Inokuchi (2009).
Activin signaling as an emerging target for therapeutic interventions.
  Cell Commun Signal, 7, 15.  
19324848 M.A.Akinci, H.Turner, M.Taveras, A.Barash, Z.Wang, P.Reinach, and J.M.Wolosin (2009).
Molecular profiling of conjunctival epithelial side-population stem cells: atypical cell surface markers and sources of a slow-cycling phenotype.
  Invest Ophthalmol Vis Sci, 50, 4162-4172.  
19129173 M.Asai-Coakwell, C.R.French, M.Ye, K.Garcha, K.Bigot, A.G.Perera, K.Staehling-Hampton, S.C.Mema, B.Chanda, A.Mushegian, S.Bamforth, M.R.Doschak, G.Li, M.B.Dobbs, P.F.Giampietro, B.P.Brooks, P.Vijayalakshmi, Y.Sauvé, M.Abitbol, P.Sundaresan, V.van Heyningen, O.Pourquié, T.M.Underhill, A.J.Waskiewicz, and O.J.Lehmann (2009).
Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypes.
  Hum Mol Genet, 18, 1110-1121.  
19419965 M.M.Phelan, C.T.Thai, D.C.Soares, R.T.Ogata, P.N.Barlow, and J.Bramham (2009).
Solution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric Arrangement.
  J Biol Chem, 284, 19637-19649.
PDB code: 2wcy
19806200 R.Patani, A.Compston, C.A.Puddifoot, D.J.Wyllie, G.E.Hardingham, N.D.Allen, and S.Chandran (2009).
Activin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity.
  PLoS One, 4, e7327.  
19208630 V.Veverka, A.J.Henry, P.M.Slocombe, A.Ventom, B.Mulloy, F.W.Muskett, M.Muzylak, K.Greenslade, A.Moore, L.Zhang, J.Gong, X.Qian, C.Paszty, R.J.Taylor, M.K.Robinson, and M.D.Carr (2009).
Characterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION.
  J Biol Chem, 284, 10890-10900.
PDB code: 2k8p
18350601 A.Deli, E.Kreidl, S.Santifaller, B.Trotter, K.Seir, W.Berger, R.Schulte-Hermann, C.Rodgarkia-Dara, and M.Grusch (2008).
Activins and activin antagonists in hepatocellular carcinoma.
  World J Gastroenterol, 14, 1699-1709.  
18184649 A.L.Blount, J.M.Vaughan, W.W.Vale, and L.M.Bilezikjian (2008).
A Smad-binding element in intron 1 participates in activin-dependent regulation of the follistatin gene.
  J Biol Chem, 283, 7016-7026.  
17878607 K.Tsuchida, M.Nakatani, A.Uezumi, T.Murakami, and X.Cui (2008).
Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
  Endocr J, 55, 11-21.  
18200608 O.Okhrimenko, and I.Jelesarov (2008).
A survey of the year 2006 literature on applications of isothermal titration calorimetry.
  J Mol Recognit, 21, 1.  
18948415 R.Esterberg, J.M.Delalande, and A.Fritz (2008).
Tailbud-derived Bmp4 drives proliferation and inhibits maturation of zebrafish chordamesoderm.
  Development, 135, 3891-3901.  
18768470 R.Stamler, H.T.Keutmann, Y.Sidis, C.Kattamuri, A.Schneyer, and T.B.Thompson (2008).
The Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY.
  J Biol Chem, 283, 32831-32838.
PDB code: 3b4v
18397882 Y.Makanji, K.L.Walton, M.C.Wilce, K.L.Chan, D.M.Robertson, and C.A.Harrison (2008).
Suppression of inhibin A biological activity by alterations in the binding site for betaglycan.
  J Biol Chem, 283, 16743-16751.  
17295905 D.Weber, A.Kotzsch, J.Nickel, S.Harth, A.Seher, U.Mueller, W.Sebald, and T.D.Mueller (2007).
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
  BMC Struct Biol, 7, 6.
PDB codes: 2h62 2h64
17483092 J.L.Zhang, Y.Huang, L.Y.Qiu, J.Nickel, and W.Sebald (2007).
von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms.
  J Biol Chem, 282, 20002-20014.  
17898761 K.D.Kavanagh, A.R.Evans, and J.Jernvall (2007).
Predicting evolutionary patterns of mammalian teeth from development.
  Nature, 449, 427-432.  
17925852 S.A.Morris, A.D.Almeida, H.Tanaka, K.Ohta, and S.Ohnuma (2007).
Tsukushi Modulates Xnr2, FGF and BMP Signaling: Regulation of Xenopus Germ Layer Formation.
  PLoS ONE, 2, e1004.  
17140726 T.F.Lerch, M.Xu, T.S.Jardetzky, K.E.Mayo, I.Radhakrishnan, R.Kazer, L.D.Shea, and T.K.Woodruff (2007).
The structures that underlie normal reproductive function.
  Mol Cell Endocrinol, 267, 1-5.  
17409095 T.F.Lerch, S.Shimasaki, T.K.Woodruff, and T.S.Jardetzky (2007).
Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions.
  J Biol Chem, 282, 15930-15939.
PDB code: 2p6a
17564495 X.P.Wang, M.Suomalainen, S.Felszeghy, L.C.Zelarayan, M.T.Alonso, M.V.Plikus, R.L.Maas, C.M.Chuong, T.Schimmang, and I.Thesleff (2007).
An integrated gene regulatory network controls stem cell proliferation in teeth.
  PLoS Biol, 5, e159.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer